Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gorlia, Thierry"'
Autor:
van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: m.vandenbent@erasmusmc.nl., Tesileanu CMS; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Wick W; Neurologische Klinik und Nationales Zentrum für Tumorerkrankungen Universitätsklinik Heidelberg, Heidelberg, Germany., Sanson M; Sorbonne Universités, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM AP-HP, Paris, France; Hôpital Univeristaires Pitié-salpêtrière -Chales Foix, service de Neurologie 2-Mazarin, Paris, France., Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy., Clement PM; Department of Oncology, KU Leuven and Department of General Medical Oncology, UZ Leuven, Leuven Cancer Institute, Leuven, Belgium., Erridge S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburgh, UK., Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA., Nowak AK; Medical School of Medicine and Pharmacology, University of Western Australia, Crawley, WA, Australia; CoOperative Group for NeuroOncology, University of Sydney, Camperdown, NSW, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia., Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Wheeler H; Northern Sydney Cancer Centre, St Leonards, Sydney, NSW, Australia., Chinot OL; Aix-Marseille University, AP-HM, Neuro-Oncology division, Marseille, France., Gill S; Department of Medical Oncology, Alfred Hospital, Melbourne, QLD, Australia., Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA., Taal W; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy., Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., McBain C; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Reijneveld J; Brain Tumor Center Amsterdam and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands; Department of Neurology, Academic Medical Center, Amsterdam, Netherlands., Enting RH; Department of Neurology, UMCG, University of Groningen, Groningen, Netherlands., Caparrotti F; Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland., Lesimple T; Department of Clinical Oncology, Comprehensive Cancer Center Eugène Marquis, Rennes, France., Clenton S; Weston Park Hospital, Sheffield, UK., Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, Netherlands., Lim E; Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany., Hau P; Wilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital, Regensburg, Regensburg, Germany., Dhermain F; Radiotherapy Department, Gustave Roussy University Hospital, Villejuif, Cedex, France., de Heer I; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Aldape K; Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester MN, USA., Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Kros JM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Wesseling P; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pathology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands., Nuyens S; EORTC, Brussels, Belgium., Golfinopoulos V; EORTC, Brussels, Belgium., Gorlia T; EORTC, Brussels, Belgium., French P; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Baumert BG; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Center (MUMC) GROW (School for Oncology), Maastricht, Netherlands; Institute of Radiation-Oncology, Cantonal Hospital Graubünden, Chur, Switzerland.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Jun; Vol. 22 (6), pp. 813-823. Date of Electronic Publication: 2021 May 14.
Autor:
Tesileanu CMS; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Vallentgoed WR; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Sanson M; Sorbonne Universités UPMC University of Paris 06, Inserm, CNRS, APHP, Institut du Cerveau et de la Moelle (ICM)-Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, 75013, Paris, France., Taal W; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Clement PM; Department of Oncology, KU Leuven, Leuven, Belgium.; Department of General Medical Oncology, UZ Leuven, Leuven, Belgium., Wick W; Neurologische Klinik und Nationales Zentrum für Tumorerkrankungen Universitätsklinik, Heidelberg, Germany., Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy., Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Bruxelles, Belgium., Chinot OL; Neuro-Oncology Division, Aix-Marseille University, AP-HM, Marseille, France., Wheeler H; Northern Sydney Cancer Centre, St Leonards, NSW, 2065, Australia., Gill S; Department Medical Oncology, Alfred Hospital, Melbourne, Australia., Griffin M; Department of Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK., Rogers L; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA., Rudà R; Department of Neuro-Oncology, City of Health and Science Hospital and University of Turin, Turin, Italy., Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., McBain C; Department of Clinical Oncology, The Christie NHS FT, Manchester, UK., Reijneveld J; Brain Tumor Center Amsterdam and Department of Neurology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Enting RH; Department of Neurology, UMCG, University of Groningen, Groningen, The Netherlands., Caparrotti F; Department of Radiation Oncology, University Hospital of Geneva, Geneva, Switzerland., Lesimple T; Department of Clinical Oncology, Comprehensive Cancer Center Eugène Marquis, Rennes, France., Clenton S; Weston Park Hospital, Sheffield, UK., Gijtenbeek A; Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands., Lim E; Department of Clinical Oncology, Plymouth Hospitals NHS Trust, Plymouth, UK., de Vos F; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Mulholland PJ; University College Hospital, London, UK., Taphoorn MJB; MC Haaglanden, Den Haag, The Netherlands., de Heer I; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Hoogstrate Y; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., de Wit M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Boggiani L; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Venneker S; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Oosting J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Erridge S; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburg, UK., Vogelbaum MA; Department of NeuroOncology, Moffitt Cancer Center, Tampa, FL, USA., Nowak AK; School of Medicine and Pharmacology, University of Western Australia, 35 Stirling, Highway Crawley, WA, 6009, Australia.; CoOperative Group for NeuroOncology, University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA, 6009, Australia., Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Kros JM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Wesseling P; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Aldape K; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Dubbink HJ; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Baumert B; Department of Radiation-Oncology (MAASTRO), Maastricht University Medical Center (MUMC) and GROW (School for Oncology), Maastricht, The Netherlands.; Institute of Radiation-Onology, Chur, Switzerland., Golfinopoulos V; EORCT HQ, Brussels, Belgium., Gorlia T; EORCT HQ, Brussels, Belgium., van den Bent M; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., French PJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. p.french@erasmusmc.nl.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2021 Jun; Vol. 141 (6), pp. 945-957. Date of Electronic Publication: 2021 Mar 19.
Autor:
Draaisma K; Erasmus University Medical Center, Rotterdam, the Netherlands.; Université de Liège, Liège, Belgium., Chatzipli A; Wellcome Sanger Institute, Hinxton, United Kingdom., Taphoorn M; Haaglanden Medisch Centrum, the Hague, the Netherlands., Kerkhof M; Haaglanden Medisch Centrum, the Hague, the Netherlands., Weyerbrock A; Universitätsklinikum Freiburg, Freiburg, Germany., Sanson M; Sorbonne Université, Paris, France., Hoeben A; Maastricht University Medical Center, Maastricht, the Netherlands., Lukacova S; Aarhus University Hospital, Aarhus, Denmark., Lombardi G; Veneto Institute of Oncology-IRCCS, Padua, Italy., Leenstra S; Elizabeth-TweeSteden Hospital, Tilburg, the Netherlands., Hanse M; Elizabeth-TweeSteden Hospital, Tilburg, the Netherlands., Fleischeuer R; Elizabeth-TweeSteden Hospital, Tilburg, the Netherlands., Watts C; University of Birmingham, Birmingham, United Kingdom., McAbee J; National Cancer Institute, Bethesda, MD., Angelopoulos N; Wellcome Sanger Institute, Hinxton, United Kingdom., Gorlia T; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Golfinopoulos V; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Kros JM; Erasmus University Medical Center, Rotterdam, the Netherlands., Verhaak RGW; Jackson Lab for Genomic Medicine, Farmington, CT., Bours V; Université de Liège, Liège, Belgium., van den Bent MJ; Erasmus University Medical Center, Rotterdam, the Netherlands., McDermott U; Wellcome Sanger Institute, Hinxton, United Kingdom., Robe PA; Université de Liège, Liège, Belgium.; University Medical Center Utrecht, Utrecht, the Netherlands., French PJ; Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Jan 01; Vol. 38 (1), pp. 81-99. Date of Electronic Publication: 2019 Nov 19.
Autor:
Shirahata M; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Ono T; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan., Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Schrimpf D; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Reuss DE; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Sahm F; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Koelsche C; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Wefers A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Reinhardt A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Huang K; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Sievers P; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Shimizu H; Department of Neurosurgery, Akita University Graduate School of Medicine, Akita, Japan., Nanjo H; Akita University Hospital Division of Clinical Pathology, Akita, Japan.; Medical Center, Hidaka, Japan., Kobayashi Y; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Miyake Y; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Suzuki T; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Adachi JI; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Mishima K; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Sasaki A; Department of Pathology, Saitama Medical University International Medical Center, Hidaka, Japan., Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Hidaka, Japan., Bewerunge-Hudler M; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ryzhova M; NN Burdenko Neurosurgical Institute, 5-th Tverskaya_Yamskaya str. 16, Moscow, Russia., Absalyamova O; NN Burdenko Neurosurgical Institute, 5-th Tverskaya_Yamskaya str. 16, Moscow, Russia., Golanov A; NN Burdenko Neurosurgical Institute, 5-th Tverskaya_Yamskaya str. 16, Moscow, Russia., Sinn P; Department of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Platten M; Department of Neurology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Jungk C; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany., Winkler F; Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Wick A; Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Hänggi D; Department of Neurosurgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany., Unterberg A; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany., Pfister SM; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, University Hospital Heidelberg, Heidelberg, Germany., Jones DTW; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., van den Bent M; The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hegi M; Laboratory of Brain Tumor Biology and Genetics, Neuroscience Research Center, Lausanne University Hospital, Lausanne, Switzerland.; Division of Neurosurgery, Lausanne University Hospital, Lausanne, Switzerland., French P; The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Baumert BG; Department of Radiation-Oncology (MAASTRO Clinic) and GROW (School for Oncology), Maastricht University Medical Centre, Maastricht, The Netherlands., Stupp R; Malnati Brain Tumor Institute of the Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Gorlia T; EORTC Headquarter, Brussels, Belgium., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Capper D; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ) Heidelberg, Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Neuropathology, Berlin Institute of Health, Berlin, Germany., Korshunov A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Herold-Mende C; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany., Wick W; Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Louis DN; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA., von Deimling A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. andreas.vondeimling@med.uni-heidelberg.de.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. andreas.vondeimling@med.uni-heidelberg.de.; Department for Neuropathology and CCU Neuropathology, University of Heidelberg and DKFZ, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany. andreas.vondeimling@med.uni-heidelberg.de.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2018 Jul; Vol. 136 (1), pp. 153-166. Date of Electronic Publication: 2018 Apr 23.
Autor:
van den Bent MJ; Dept Neuro-Oncology and Pathology, Daniel den Hoed Cancer Center and Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands. m.vandenbent@erasmusmc.nl, Dubbink HJ, Marie Y, Brandes AA, Taphoorn MJ, Wesseling P, Frenay M, Tijssen CC, Lacombe D, Idbaih A, van Marion R, Kros JM, Dinjens WN, Gorlia T, Sanson M
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2010 Mar 01; Vol. 16 (5), pp. 1597-604. Date of Electronic Publication: 2010 Feb 16.
Autor:
Draaisma, Kaspar, Tesileanu, C Mircea S, de Heer, Iris, Klein, Martin, Smits, Marion, Reijneveld, Jaap C, Clement, Paul M, de Vos, Filip Y F, Wick, Antje, Mulholland, Paul J, Taphoorn, Martin J B, Weller, Michael, Chinot, Olivier L, Kros, Johan M, Verschuere, Tina, Coens, Corneel, Golfinopoulos, Vassilis, Gorlia, Thierry, Idbaih, Ahmed, Robe, Pierre A, van den Bent, Martin J, French, Pim J
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, 28(11), 2440-2448. American Association for Cancer Research Inc.
Clinical Cancer Research, 28(11), 2440-2448. American Association for Cancer Research Inc.
Draaisma, K, S. Tesileanu, C M, de Heer, I, Klein, M, Smits, M, Reijneveld, J C, Clement, P M, de Vos, F Y F, Wick, A, Mulholland, P J, Taphoorn, M J B, Weller, M, Chinot, O L, Kros, J M, Verschuere, T, Coens, C, Golfinopoulos, V, Gorlia, T, Idbaih, A, Robe, P A, van den Bent, M J & French, P J 2022, ' Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence : a Report from the EORTC 26091 TAVAREC Trial ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 28, no. 11, pp. 2440-2448 . https://doi.org/10.1158/1078-0432.CCR-21-3725
Clinical Cancer Research, 28(11), 2440-2448. American Association for Cancer Research Inc.
Draaisma, K, S. Tesileanu, C M, de Heer, I, Klein, M, Smits, M, Reijneveld, J C, Clement, P M, de Vos, F Y F, Wick, A, Mulholland, P J, Taphoorn, M J B, Weller, M, Chinot, O L, Kros, J M, Verschuere, T, Coens, C, Golfinopoulos, V, Gorlia, T, Idbaih, A, Robe, P A, van den Bent, M J & French, P J 2022, ' Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence : a Report from the EORTC 26091 TAVAREC Trial ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 28, no. 11, pp. 2440-2448 . https://doi.org/10.1158/1078-0432.CCR-21-3725
Purpose: Despite recent advances in the molecular characterization of gliomas, it remains unclear which patients benefit most from which second-line treatments. The TAVAREC trial was a randomized, open-label phase II trial assessing the benefit of th
Autor:
Preusser, Matthias, Hoeftberger, Romana, Woehrer, Adelheid, Gelpi, Ellen, Kouwenhoven, Mathilde, Kros, Johan M, Sanson, Marc, Idbaih, Ahmed, Brandes, Alba A, Heinzl, Harald, Gorlia, Thierry, Hainfellner, Johannes A, van den Bent, Martin
Publikováno v:
Histopathology; May2012, Vol. 60 Issue 6, p885-894, 10p, 1 Black and White Photograph, 5 Charts, 2 Graphs